MIRA Pharmaceuticals closes $8.9M IPO; shares begin trading on Nasdaq

MIRA PHARMACEUTICALS, INC.

Priced 1,275,000 shares at $7.00; gross proceeds of $8.9M.
Nasdaq Capital Market listing under 'MIRA'; trading began Aug 3, 2023.
Underwriters granted 45-day over-allotment option for 191,250 shares.
Issued representative's warrants for 63,750 shares at $7.00, exercisable for 5 years.
Shares issued to MZ as compensation for IPO-related services remain unregistered.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

MIRA PHARMACEUTICALS, INC. entered into Underwriting Agreement with Kingswood Investments, division of Kingswood Capital Partners, LLC (effective 2023-08-02).

Action: entry
Agreement: underwriting
Counterparty: Kingswood Investments, division of Kingswood Capital Partners, LLC
Effective: 2023-08-02

Exact text from the filing

On August 2, 2023, MIRA Pharmaceuticals, Inc. (the “Company”) entered into an Underwriting Agreement with Kingswood Investments, division of Kingswood Capital Partners, LLC (“Kingswood”) on behalf of itself and as representative of the underwriters named therein (the “Underwriting Agreement”), pursuant to which the Company issued and sold, in an underwritten public offering (the “Public Offering”), 1,275,000 shares of common stock, $0.0001 par value per share (“Common Stock”).

View on SEC.gov

629 material agreements filed in the last 30 days. Browse all material agreements →

MIRA PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-027053

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.